JP6298768B2 - ７−置換ハンファンギチンｂ誘導体、その調製方法及び使用 - Google Patents

７−置換ハンファンギチンｂ誘導体、その調製方法及び使用 Download PDF

Info

Publication number
JP6298768B2
JP6298768B2 JP2014552508A JP2014552508A JP6298768B2 JP 6298768 B2 JP6298768 B2 JP 6298768B2 JP 2014552508 A JP2014552508 A JP 2014552508A JP 2014552508 A JP2014552508 A JP 2014552508A JP 6298768 B2 JP6298768 B2 JP 6298768B2
Authority
JP
Japan
Prior art keywords
substituted
fangquinoline
substituent
cancer
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2014552508A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015504075A (ja
JP2015504075A5 (enExample
Inventor
フランク ロン
フランク ロン
ロンツェン シュー
ロンツェン シュー
ホンシ ライ
ホンシ ライ
フーウェン シェ
フーウェン シェ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hangzhou Bensheng Pharmaceutical Co Ltd
Original Assignee
Hangzhou Bensheng Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Bensheng Pharmaceutical Co Ltd filed Critical Hangzhou Bensheng Pharmaceutical Co Ltd
Publication of JP2015504075A publication Critical patent/JP2015504075A/ja
Publication of JP2015504075A5 publication Critical patent/JP2015504075A5/ja
Application granted granted Critical
Publication of JP6298768B2 publication Critical patent/JP6298768B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2014552508A 2012-01-21 2013-01-21 ７−置換ハンファンギチンｂ誘導体、その調製方法及び使用 Expired - Fee Related JP6298768B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2012070698 2012-01-21
CNPCT/CN2012/070698 2012-01-21
PCT/CN2013/070800 WO2013107428A1 (zh) 2012-01-21 2013-01-21 7-位取代的汉防己乙素衍生物、及其制备方法和应用

Publications (3)

Publication Number Publication Date
JP2015504075A JP2015504075A (ja) 2015-02-05
JP2015504075A5 JP2015504075A5 (enExample) 2016-02-25
JP6298768B2 true JP6298768B2 (ja) 2018-03-20

Family

ID=48798682

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014552508A Expired - Fee Related JP6298768B2 (ja) 2012-01-21 2013-01-21 ７−置換ハンファンギチンｂ誘導体、その調製方法及び使用

Country Status (6)

Country Link
US (1) US9328122B2 (enExample)
EP (1) EP2805954B1 (enExample)
JP (1) JP6298768B2 (enExample)
CN (1) CN104039794B (enExample)
DK (1) DK2805954T3 (enExample)
WO (1) WO2013107428A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016023404A1 (zh) * 2014-08-15 2016-02-18 贵州省中国科学院天然产物化学重点实验室 双苄基异喹啉衍生物、其制备方法及其在肝病的治疗与预防中的用途
CN107033157B (zh) * 2016-02-03 2020-05-05 贵州省中国科学院天然产物化学重点实验室 双苄基异喹啉衍生物及其在制备用于治疗或预防肿瘤的药物中的用途
CN109776553B (zh) * 2019-01-15 2020-05-29 山东师范大学 福己素及其制备方法和应用
CN110156808B (zh) * 2019-06-21 2022-01-18 华中农业大学 具有杀菌活性的防己诺林碱-氨基甲酸酯类衍生物
CN111675716B (zh) * 2020-06-15 2022-09-13 山东省农业科学院农产品研究所 一种具有抗癌活性的防己诺林碱衍生物及制备方法、应用
CN112250690B (zh) * 2020-09-24 2022-07-15 山东师范大学 磺酰基防己诺林碱类化合物及其制备方法和应用
CN114031623B (zh) * 2021-11-12 2023-04-11 山西医科大学 一种c14位氨基取代粉防己碱衍生物及其制备和应用
CN116731031A (zh) * 2023-06-16 2023-09-12 贵州药法自然医药科技有限公司 芬氏唐松草碱衍生物及其应用
WO2026105158A1 (en) * 2024-11-16 2026-05-21 Translational Health Science And Technology Institute Bis(benzylisoquinoline) alkaloids as tlr4 agonist
CN119792287B (zh) * 2025-03-17 2025-08-08 山东第二医科大学 防己诺林碱在制备stag2突变急性髓系白血病治疗药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0678232B2 (ja) * 1986-03-07 1994-10-05 株式会社ツムラ アンジオテンシンｉ転換酵素阻害剤
JPH02134382A (ja) * 1988-11-14 1990-05-23 Kaken Shiyouyaku Kk ビスベンジルイソキノリン誘導体
JPH02243627A (ja) * 1989-03-16 1990-09-27 Tsumura & Co 狭心症治療薬
CN1111160C (zh) * 2000-09-08 2003-06-11 成都康弘制药有限公司 双苄基异喹啉类生物碱和药物组合物及用途
CN1511528A (zh) 2002-12-30 2004-07-14 北京大学第一医院 防己诺林碱在抑制血管生成药物中的应用
CN1511527A (zh) * 2002-12-31 2004-07-14 北京大学第一医院 粉防已碱在抑制血管生成药物中的应用
CN101371839B (zh) 2008-10-08 2010-11-03 中国科学院化学研究所 双苄基异喹啉类生物碱的新用途

Also Published As

Publication number Publication date
JP2015504075A (ja) 2015-02-05
CN104039794A (zh) 2014-09-10
US20140357647A1 (en) 2014-12-04
US9328122B2 (en) 2016-05-03
EP2805954B1 (en) 2019-06-19
EP2805954A4 (en) 2015-10-21
EP2805954A1 (en) 2014-11-26
WO2013107428A1 (zh) 2013-07-25
CN104039794B (zh) 2017-11-03
DK2805954T3 (da) 2019-09-23

Similar Documents

Publication Publication Date Title
JP2015504075A (ja) ７−置換ハンファンギチンｂ誘導体、その調製方法及び使用
JP6043361B2 (ja) オレアノール酸アミド化誘導体、その調製方法及び使用
JP5976810B2 (ja) ５−置換テトランドリン誘導体、その調製方法及びその使用
JP6149043B2 (ja) ２−アミノ化メチレン又は２−エステル化メチレンタンシノン誘導体、並びにその調製方法及び使用
EP2862869B1 (en) Acylated derivatives of polyphyllin i, preparation method therefor and application thereof
KR102452412B1 (ko) 트리프톨리드의 c14-히드록실 에스테르화 아미노산 유도체, 및 그의 제조 방법 및 용도
JP6068472B2 (ja) アミノ化ホモハリントニン誘導体、その調製方法及び使用
JP6059734B2 (ja) ２−アルキル−又は２−アリール−置換タンシノン誘導体、その調製方法及び適用
JP5701387B2 (ja) ベルバミンのジカルボキシミド誘導体、その調製方法及び使用
JP5993455B2 (ja) ホモハリントニンアシル化誘導体、その調製方法及び使用
CN112778393B (zh) 欧夹竹桃苷衍生物及其制备方法、药物组合物和用途
CN104557544A (zh) C-10甲氧基紫杉烷类衍生物及其肿瘤多药耐药逆转剂的用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141016

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160105

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160105

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160728

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160804

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161104

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20170309

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170710

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170719

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20170929

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171019

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180119

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180130

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180226

R150 Certificate of patent or registration of utility model

Ref document number: 6298768

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees